245 related articles for article (PubMed ID: 36618838)
1. Risk of endometrial, ovarian, and breast cancers in women with polycystic ovary syndrome: A systematic review and meta-analysis.
Amiri M; Bidhendi-Yarandi R; Fallahzadeh A; Marzban Z; Ramezani Tehrani F
Int J Reprod Biomed; 2022 Nov; 20(11):893-914. PubMed ID: 36618838
[TBL] [Abstract][Full Text] [Related]
2. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis.
Barry JA; Azizia MM; Hardiman PJ
Hum Reprod Update; 2014; 20(5):748-58. PubMed ID: 24688118
[TBL] [Abstract][Full Text] [Related]
3. Risk of Gynecological Cancers in Women With Polycystic Ovary Syndrome and the Pathophysiology of Association.
Shetty C; Rizvi SMHA; Sharaf J; Williams KD; Tariq M; Acharekar MV; Guerrero Saldivia SE; Unnikrishnan SN; Chavarria YY; Akindele AO; Jalkh APC; Eastmond AK; Hamid P
Cureus; 2023 Apr; 15(4):e37266. PubMed ID: 37162768
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary syndrome and the risk of endometrial, ovarian and breast cancer: An updated meta-analysis.
Li Z; Wang YH; Wang LL; Hu DT; Teng Y; Zhang TY; Yan ZY; Wang F; Zou YF
Scott Med J; 2022 Aug; 67(3):109-120. PubMed ID: 35686317
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review.
Harris HR; Terry KL
Fertil Res Pract; 2016; 2():14. PubMed ID: 28620541
[TBL] [Abstract][Full Text] [Related]
6. Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression.
Amiri M; Ramezani Tehrani F; Behboudi-Gandevani S; Bidhendi-Yarandi R; Carmina E
Reprod Biol Endocrinol; 2020 Mar; 18(1):23. PubMed ID: 32183820
[TBL] [Abstract][Full Text] [Related]
7. The association between metabolic syndrome and polycystic ovary syndrome: A systematic review and meta-analysis.
Otaghi M; Azami M; Khorshidi A; Borji M; Tardeh Z
Diabetes Metab Syndr; 2019; 13(2):1481-1489. PubMed ID: 31336510
[TBL] [Abstract][Full Text] [Related]
8. Association between polycystic ovarian syndrome and endometrial, ovarian, and breast cancer: A population-based cohort study in Taiwan.
Ding DC; Chen W; Wang JH; Lin SZ
Medicine (Baltimore); 2018 Sep; 97(39):e12608. PubMed ID: 30278576
[TBL] [Abstract][Full Text] [Related]
9. The polycystic ovary syndrome and gynecological cancer risk.
Meczekalski B; Pérez-Roncero GR; López-Baena MT; Chedraui P; Pérez-López FR
Gynecol Endocrinol; 2020 Apr; 36(4):289-293. PubMed ID: 32103691
[TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review.
Chittenden BG; Fullerton G; Maheshwari A; Bhattacharya S
Reprod Biomed Online; 2009 Sep; 19(3):398-405. PubMed ID: 19778486
[TBL] [Abstract][Full Text] [Related]
11. Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? Meta-analysis and systematic review.
Magzoub R; Kheirelseid EAH; Perks C; Lewis S
Eur J Obstet Gynecol Reprod Biol; 2022 Apr; 271():38-62. PubMed ID: 35149444
[TBL] [Abstract][Full Text] [Related]
12. The effect of the polycystic ovary syndrome and hypothyroidism on the risk of fibrocystic breast changes: a meta-analysis.
Kohnepoushi P; Dehghanbanadaki H; Mohammadzedeh P; Nikouei M; Moradi Y
Cancer Cell Int; 2022 Mar; 22(1):125. PubMed ID: 35305643
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis.
Ramezani Tehrani F; Amiri M; Behboudi-Gandevani S; Bidhendi-Yarandi R; Carmina E
Gynecol Endocrinol; 2020 Jan; 36(1):12-23. PubMed ID: 31385729
[TBL] [Abstract][Full Text] [Related]
14. Risk of endometrial cancer in patients with polycystic ovarian syndrome: A meta‑analysis.
Johnson JE; Daley D; Tarta C; Stanciu PI
Oncol Lett; 2023 Apr; 25(4):168. PubMed ID: 36960190
[TBL] [Abstract][Full Text] [Related]
15. Individual effects of GSTM1 and GSTT1 polymorphisms on the risk of polycystic ovarian syndrome: A systematic review and meta-analysis.
Makoui MH; Fekri S; Makoui RH; Ansari N
Turk J Obstet Gynecol; 2023 Dec; 20(4):314-319. PubMed ID: 38073224
[TBL] [Abstract][Full Text] [Related]
16. Association between polycystic ovary syndrome and the risk of malignant gynecologic cancers (ovarian, endometrial, and cervical): A population-based study from the U.S.A. National Inpatient Sample 2016-2019.
Abu-Zaid A; Baradwan S; Alyafi M; Al Baalharith M; Alsehaimi SO; Alsabban M; Alsharif SA; Alqarni SMS; Albelwi H; Jamjoom MZ; Saleh SAK; Adly HM; Alomar O; Salem H
Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 299():283-288. PubMed ID: 38941743
[TBL] [Abstract][Full Text] [Related]
17. Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysis.
Ramezani-Binabaj M; Motalebi M; Karimi-Sari H; Rezaee-Zavareh MS; Alavian SM
Hepat Mon; 2014 Nov; 14(11):e23235. PubMed ID: 25598791
[TBL] [Abstract][Full Text] [Related]
18. Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis.
Salari N; Nankali A; Ghanbari A; Jafarpour S; Ghasemi H; Dokaneheifard S; Mohammadi M
Arch Gynecol Obstet; 2024 Jun; ():. PubMed ID: 38922413
[TBL] [Abstract][Full Text] [Related]
19. Effect of lifestyle modifications on anthropometric, clinical, and biochemical parameters in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis.
Abdolahian S; Tehrani FR; Amiri M; Ghodsi D; Yarandi RB; Jafari M; Majd HA; Nahidi F
BMC Endocr Disord; 2020 May; 20(1):71. PubMed ID: 32429890
[TBL] [Abstract][Full Text] [Related]
20. Serum and follicular fluid chemerin and chemerin mRNA expression in women with polycystic ovary syndrome: Systematic review and meta-analysis.
Mansoori A; Amoochi-Foroushani G; Zilaee M; Hosseini SA; Azhdari M
Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00307. PubMed ID: 34699139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
